Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2

The Elecsys Anti-SARS-CoV-2 immunoassay (Roche Diagnostics) was developed to provide accurate, reliable detection of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We evaluated sensitivity, specificity, cross-reactivity, and agreement with a vesicular stomatitis virus-ba...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Microbiol
Autors principals: Muench, Peter, Jochum, Simon, Wenderoth, Verena, Ofenloch-Haehnle, Beatus, Hombach, Michael, Strobl, Matthias, Sadlowski, Henrik, Sachse, Christopher, Torriani, Giulia, Eckerle, Isabella, Riedel, Alexander
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2020
Matèries:
Virology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7512151/
https://ncbi.nlm.nih.gov/pubmed/32747400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.01694-20
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars